Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | LAP3 | P28838 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22235872 | 0.86 | BTN3A1 (0.38) | LPAR2LPAR3 | |
| SCHEMBL9306339 | 0.84 | — | — | |
| SCHEMBL11311404 | 0.84 | — | — | |
| SCHEMBL2725372 | 0.82 | SMPD1 (0.35) | SMPD1 | |
| SCHEMBL2352711 | 0.81 | LPAR2 (0.32) | LPAR2LPAR3 | |
| SCHEMBL22235870 | 0.80 | — | — | |
| SCHEMBL14531046 | 0.80 | — | — | |
| SCHEMBL9492540 | 0.79 | LPAR2 (0.32) | LPAR2LPAR3 | |
| SCHEMBL14531526 | 0.79 | — | — | |
| SCHEMBL17923999 | 0.79 | LPAR2 (0.36) | SMPD1LPAR2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5330622-A | Applying glyoxal, dimeric alkylketene and diethanolamine salt of perfluoroalkyl ethyl phosphate to base with aid of impregnating press | AUSSEDAT-REY (FR) | 1994-07-19 | — | — | US | claimed |
| US-20220162188-A1 | ISOPRENOIDS AND METHODS OF MAKING THEREOF | NORTH CAROLINA STATE UNIVERSITY | 2022-05-26 | — | — | US | disclosed |
| EP-3911740-A1 | ISOPRENOIDS AND METHODS OF MAKING THEREOF | North Carolina State University (US) | 2021-11-24 | — | — | EP | disclosed |
| WO-2020150340-A1 | ISOPRENOIDS AND METHODS OF MAKING THEREOF | NORTH CAROLINA STATE UNIVERSITY (US) | 2020-07-23 | — | — | WO | disclosed |
| US-4257987-A | SYNERGISTIC ARTHROPODICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1981-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162188-A1 | ISOPRENOIDS AND METHODS OF MAKING THEREOF | GGPS1, SQLE, FDPS | SMPD1 531/4885LPAR2 2257/4885LPAR3 2216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.